Which hedge funds own NRXP? NRX PHARMACEUTICALS INC, Q2 2026 13F holders
4 of the hedge funds tracked by WhaleCreep disclosed a position in NRXP (NRX PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $3.8m in total. The largest holder by portfolio weight is Citadel Advisors at 0.0% of its book. 4 managers opened a new position this quarter: Citadel Advisors, Marshall Wace, Renaissance Technologies LLC, Millennium Management.
4tracked managers holding
4opened this quarter
0exited this quarter
Which hedge funds hold NRXP? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Citadel Advisors | Q2 2026 | 0.0% | $2.8m | 680,043 | – | new |
| Marshall Wace | Q2 2026 | 0.0% | $795.8k | 194,580 | – | new |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $157.9k | 38,600 | – | new |
| Millennium Management | Q2 2026 | 0.0% | $50.3k | 12,305 | – | new |
How has hedge fund ownership of NRXP changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 4 | $3.8m |
| Q4 2025 | 1 | $43.3k |
| Q3 2025 | 1 | $423.0k |
| Q1 2024 | 1 | $89.0k |
| Q4 2023 | 1 | $92.0k |
| Q3 2023 | 1 | $43.0k |
| Q2 2023 | 1 | $16.0k |
| Q1 2023 | 1 | $17.0k |
| Q4 2022 | 1 | $20.0k |
| Q3 2022 | 2 | $48.0k |
| Q2 2022 | 2 | $50.0k |
| Q1 2022 | 2 | $464.0k |
| Q4 2021 | 1 | $239.0k |
| Q3 2021 | 1 | $464.0k |
| Q2 2021 | 1 | $3.4m |
Counts every tracked manager that disclosed NRXP in that quarter's filing, including managers that have since stopped filing.